Analyze Diet
Parasitology research2008; 103(2); 287-291; doi: 10.1007/s00436-008-0966-8

Evaluation of parasiticidal activity of fenbendazole, ivermectin, oxibendazole, and pyrantel pamoate in horse foals with emphasis on ascarids (Parascaris equorum) in field studies on five farms in Central Kentucky in 2007.

Abstract: Horse foals on five farms in Central Kentucky were used in field studies in 2007 evaluating activity of paste formulations of four compounds (fenbendazole-FBZ, ivermectin-IVM, oxibendazole-OBZ, and pyrantel pamoate-PRT) against internal parasites with emphasis on ascarids (Parascaris equorum). It has been well established the last few years that there is widespread resistance of P. equorum to ivermectin. The main purpose of the present research was to obtain current data on ascaridicidal activity of FBZ, OBZ, and PRT; also, to acquire further information on ascarid resistance to ivermectin. Additionally, data were documented on drug activity on small strongyles. Detection of ascarid and strongyle eggs in feces of foals was by a qualitative method (presence or absence) or a quantitative method (eggs per gram of feces). Strongyle eggs all were assumed to be from small strongyles. This is based on fecal cultures from horses on one farm and historic records from horses in this area on excellent deworming programs. A girth tape was used to estimate the body weight of each foal so that the appropriate dose rate of each drug could be given. Many of the foals were used in more than one cycle of treatments. Efficacy of the drugs, administered intraorally, was determined by calculating the average percentage reduction (% red.) of the number of foals passing eggs after vs. before treatment: (1) FBZ at 10 mg/kg was tested on four farms; 76 foals were examined, 50 with ascarid eggs (84% red.) and 62 with strongyle eggs (0% red.); (2) IVM at 200 microg/kg was tested on three farms; 58 foals were examined, 18 with ascarid eggs (0% red.) and 48 with strongyle eggs (100% red.); (3) OBZ at 10 mg/kg was tested on three farms; 181 foals were examined, 78 with ascarid eggs (94% red.) and 79 with strongyle eggs (0% red.); (4) PRT was tested on two farms, one farm at 1x (6.6 mg base/kg); 42 were foals examined, 16 with ascarid eggs (0% red.) and 33 with strongyle eggs (12% red.) and one farm at 2x (13.2 mg base/kg); 18 foals were examined, 13 with ascarid eggs (23% red.) and 15 with strongyle eggs (27% red.).
Publication Date: 2008-05-10 PubMed ID: 18470536DOI: 10.1007/s00436-008-0966-8Google Scholar: Lookup
The Equine Research Bank provides access to a large database of publicly available scientific literature. Inclusion in the Research Bank does not imply endorsement of study methods or findings by Mad Barn.
  • Journal Article

Summary

This research summary has been generated with artificial intelligence and may contain errors and omissions. Refer to the original study to confirm details provided. Submit correction.

This research conducted field studies in 2007 on five horse farms in Central Kentucky to evaluate the effectiveness of four drugs on treating internal parasites, in particular, ascarids, in horse foals.

Study Design and Procedure

  • The researchers used paste formulations of four compounds for the study: fenbendazole (FBZ), ivermectin (IVM), oxibendazole (OBZ), and pyrantel pamoate (PRT). The main focus was on combating ascarids (Parascaris equorum), a kind of roundworm, as there is widespread resistance to the commonly used IVM.
  • Apart from ascarids, the study also aimed to gather data on small strongyles, another type of internal parasite in horses. To identify the presence of these parasites, researchers analyzed horse fecal samples using a qualitative (presence or absence) or quantitative method (eggs per gram of feces).
  • To ensure the correct dosage, a girth tape was used to estimate each foal’s body weight. Some foals underwent more than one treatment cycle.
  • The efficacy of the tested drugs was assessed by calculating the average reduction in the number of foals passing eggs after treatment compared to before treatment.

Results

  • FBZ was tested on four farms on 76 foals. It reduced ascarid eggs in 50 foals by 84% but showed 0% reduction in strongyle eggs in 62 foals.
  • IVM was tested on three farms on 58 foals. It demonstrated no reduction (0%) in ascarid eggs in 18 foals but fully eliminated (100% reduction) strongyle eggs in 48 foals.
  • OBZ was tested on three farms on 181 foals. It led to a reduction of 94% for ascarid eggs (in 78 foals) but showed no effect (0% reduction) against strongyle eggs (in 79 foals).
  • PRT was tested on two farms across 60 foals at two different doses. At the smaller dose, it showed a 0% reduction in ascarid eggs and a 12% reduction in strongyle eggs. At the larger dose, reductions were 23% for ascarid eggs and 27% for strongyle eggs.

Conclusion

  • The results indicated substantial differences in the impact of different drugs on ascarid and strongyle infestations in horse foals. Both FBZ and OBZ demonstrated significant reductions in ascarid egg counts while IVM and PRT showed less effectiveness.
  • It’s important to note that none of these drugs, except for IVM, had a noticeable effect on strongyle infestations. IVM was completely effective against strongyles, showing a 100% reduction in strongyle egg count.

Cite This Article

APA
Lyons ET, Tolliver SC, Ionita M, Collins SS. (2008). Evaluation of parasiticidal activity of fenbendazole, ivermectin, oxibendazole, and pyrantel pamoate in horse foals with emphasis on ascarids (Parascaris equorum) in field studies on five farms in Central Kentucky in 2007. Parasitol Res, 103(2), 287-291. https://doi.org/10.1007/s00436-008-0966-8

Publication

ISSN: 0932-0113
NlmUniqueID: 8703571
Country: Germany
Language: English
Volume: 103
Issue: 2
Pages: 287-291

Researcher Affiliations

Lyons, E T
  • Department of Veterinary Science, Gluck Equine Research Center, University of Kentucky, Lexington, KY 40546-0099, USA. elyons1@uky.edu
Tolliver, S C
    Ionita, M
      Collins, S S

        MeSH Terms

        • Animal Husbandry
        • Animals
        • Anthelmintics / administration & dosage
        • Anthelmintics / therapeutic use
        • Ascaridida Infections / drug therapy
        • Ascaridida Infections / parasitology
        • Ascaridida Infections / veterinary
        • Ascaridoidea / drug effects
        • Benzimidazoles / administration & dosage
        • Benzimidazoles / therapeutic use
        • Drug Resistance
        • Feces / parasitology
        • Fenbendazole / administration & dosage
        • Fenbendazole / therapeutic use
        • Horse Diseases / drug therapy
        • Horse Diseases / parasitology
        • Horses
        • Ivermectin / administration & dosage
        • Ivermectin / therapeutic use
        • Kentucky
        • Parasite Egg Count
        • Pyrantel Pamoate / administration & dosage
        • Pyrantel Pamoate / therapeutic use
        • Strongylida / drug effects
        • Strongylida Infections / drug therapy
        • Strongylida Infections / parasitology
        • Strongylida Infections / veterinary
        • Treatment Outcome

        References

        This article includes 13 references
        1. Vet Parasitol. 2007 Mar 15;144(1-2):74-80
          pubmed: 17112667
        2. Parasitol Res. 2008 Jun;103(1):209-15
          pubmed: 18389281
        3. Vet Parasitol. 2007 Apr 30;145(3-4):371-6
          pubmed: 16962243
        4. J Parasitol. 1976 Jun;62(3):453-9
          pubmed: 945338
        5. J Am Vet Med Assoc. 2004 Sep 15;225(6):903-10
          pubmed: 15485051
        6. Vet Parasitol. 1999 Aug 31;85(2-3):97-111; discussion 111-2, 215-25
          pubmed: 10485357
        7. Parasitol Res. 2006 Apr;98(5):496-500
          pubmed: 16385405
        8. Am J Vet Res. 1988 Jan;49(1):96-8
          pubmed: 3354972
        9. Vet Parasitol. 2010 Jul 15;171(1-2):111-5
          pubmed: 20307936
        10. J Am Vet Med Assoc. 2003 Aug 15;223(4):482-5, 455
          pubmed: 12930086
        11. Equine Vet J. 2003 May;35(3):246-51
          pubmed: 12755426
        12. Vet Rec. 2002 Mar 2;150(9):279-81
          pubmed: 11924584
        13. Vet Rec. 2007 Mar 31;160(13):439-40
          pubmed: 17400903